EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO ‐ DBH AML study

Morten Krogh Herlin, Eigil Kjeldsen, Jonas Abrahamsson, Nira Arad-Cohen, Daniel Cheuk, Barbara De Moerloose, Kirsi Jahnukainen, Ólafur Gísli Jónsson, Gertjan J L Kaspers, Zhanna Kovalova, Jose Maria Fernandez Navarro, Ulrika Noren-Nyström und 7 weitere

British Journal of Haematology · 2025

DOI: 10.1111/bjh.70094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Morten Krogh Herlin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kom op tegen Kanker, Graduate School of Health, Aarhus University, The Danish Childhood Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Normal karyotype acute myeloid leukaemia (NK‐AML) in children is a heterogeneous subgroup with scarce data on characteristics and prognosis. We investigated NK‐AML in a large paediatric AML cohort from four trials of the Nordic Society for Paediatric Haematology and Oncology‐Dutch Belgian Hongkong (NOPHO‐DBH) group. Among 1476 AML patients, we identified 316 NK‐AML patients (21%). NK‐AML was characterized by high frequencies of FLT3 internal tandem duplications (ITD, 33%), mutated NPM1 (28%), WT1 (25%) and CEBPA (21%). Five‐year event‐free survival (EFS) and overall survival (OS) in NK‐AML were 52% (95% confidence interval [CI]: 46–58) and 70% (CI: 65–75) respectively. Restricted to NPM1 wt cases only ( n = 959), NK‐AML was associated with unfavourable outcome (relative risk [RR] of EFS = 0.80, p = 0.014; RR of OS = 0.87, p = 0.022). NK‐AML with mutated NPM1 had excellent EFS (79%, CI: 66–88) and OS (97%, CI: 88–99), which was not influenced by concomitant FLT3 ‐ITD. In multivariable analysis, mutated NPM1 in NK‐AML was associated with favourable EFS (hazard ratio [HR]: 0.24, CI: 0.13–0.43, p < 0.001) and OS (HR: 0.10, CI: 0.03–0.35, p < 0.001). FLT3 ‐ITD was associated with inferior EFS (HR: 1.56, CI: 1.03–2.35, p = 0.035) and OS (HR: 1.91, CI: 1.11–3.31, p = 0.02). We conclude that prognosis in paediatric NK‐AML is independently affected by NPM1 and FLT3 ‐ITD status. Further molecular characterization of NK‐AML is needed, especially for NPM1 wt NK‐AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansNucleophosminChildMaleFemaleChild, PreschoolPrognosisAdolescentInfantMutationfms-Like Tyrosine Kinase 3KaryotypeNuclear ProteinsCCAAT-Enhancer-Binding Proteins

Stichwörter der Autor:innen

acute myeloid leukaemiachildhoodcytogenetics of leukaemiaprognostic factors

Substanzen

NucleophosminNPM1 protein, humanfms-Like Tyrosine Kinase 3FLT3 protein, humanNuclear ProteinsCEBPA protein, humanCCAAT-Enhancer-Binding Proteins

Autor:innen und Institutionen

  • Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Paediatrics, Institution for Clinical Sciences, Queen Silvia Children's Hospital, Gothenburg, Sweden.
  • Department of Paediatric Haemato-Oncology, Rambam Medical Centre, Haifa, Israel.
  • Hong Kong Paediatric Haematology and Oncology Study Group (HKPHOSG), Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.

ORCID-Profile: Bernward Zeller, Kristian Løvvik Juul-Dam

Förderung

  • Kom op tegen Kanker
  • Graduate School of Health, Aarhus University
  • The Danish Childhood Cancer Foundation
  • Health Research Foundation of Central Denmark Region
  • Graduate School of Health, University of Technology Sydney
  • Børnecancerfonden

Zitieren

APA

Herlin, M. K., Kjeldsen, E., Abrahamsson, J., Arad-Cohen, N., Cheuk, D., De Moerloose, B., Jahnukainen, K., Jónsson, Ó. G., Kaspers, G. J. L., Kovalova, Z., Navarro, J. M. F., Noren-Nyström, U., Palle, J., Pasaulienė, R., Saks, K., Zeller, B., Holmfeldt, L., Hasle, H., & Juul-Dam, K. L. (2025). Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO ‐ DBH AML study. British Journal of Haematology. https://doi.org/10.1111/bjh.70094

Vancouver

Herlin MK, Kjeldsen E, Abrahamsson J, Arad-Cohen N, Cheuk D, De Moerloose B, et al. Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO ‐ DBH AML study. British Journal of Haematology. 2025. doi:10.1111/bjh.70094

BibTeX
@article{Herlin2025,
  author = {Herlin, Morten Krogh and Kjeldsen, Eigil and Abrahamsson, Jonas and Arad-Cohen, Nira and Cheuk, Daniel and De Moerloose, Barbara and Jahnukainen, Kirsi and Jónsson, Ólafur Gísli and Kaspers, Gertjan J L and Kovalova, Zhanna and Navarro, Jose Maria Fernandez and Noren-Nyström, Ulrika and Palle, Josefine and Pasaulienė, Ramunė and Saks, Kadri and Zeller, Bernward and Holmfeldt, Linda and Hasle, Henrik and Juul-Dam, Kristian Løvvik},
  title = {Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO ‐ DBH AML study},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.70094}
}
Kostenlos starten →